4//SEC Filing
Doebele Robert 4
Accession 0001104659-23-090705
CIK 0001724979other
Filed
Aug 10, 8:00 PM ET
Accepted
Aug 11, 9:16 PM ET
Size
8.1 KB
Accession
0001104659-23-090705
Insider Transaction Report
Form 4
Doebele Robert
EVP, Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-08-09+99,400→ 99,400 totalExercise: $1.21Exp: 2033-08-09→ Common Stock (99,400 underlying) - Award
Stock Option (Right to Buy)
2023-08-09+49,700→ 49,700 totalExercise: $1.21Exp: 2033-08-09→ Common Stock (49,700 underlying)
Footnotes (2)
- [F1]This option represents a right to purchase a total of 99,400 shares of the Issuer's common stock, which will vest in equal installments on May 9, 2024 and February 9, 2025, subject to the Reporting Person's continued service to the Issuer.
- [F2]This option represents a right to purchase a total of 49,700 shares of the Issuer's common stock, which will vest in equal installments on May 9, 2024 and February 9, 2025, subject to the achievement of certain corporate goals and the Reporting Person's continued service to the Issuer.
Documents
Issuer
Rain Oncology Inc.
CIK 0001724979
Entity typeother
Related Parties
1- filerCIK 0001856681
Filing Metadata
- Form type
- 4
- Filed
- Aug 10, 8:00 PM ET
- Accepted
- Aug 11, 9:16 PM ET
- Size
- 8.1 KB